clinical pharmacology study of K-877

Status

Unknown

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222360

Enrollment

Registered

2014-01-10

Start date

2014-01-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia

Interventions

investigational material(s) Generic name etc : K-877 INN of investigational material : Therapeutic category code : 218 Agents for hyperlipidemias Dosage and Administration for Investigational materia

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Dyslipidemia

Exclusion criteria

Exclusion criteria: The subject who need to be taken prohibited concomitant medication

Design outcomes

Primary

Measure	Time frame
Parameter associated lipid metabolism change	—

Secondary

Measure	Time frame
Lipid parameters percent change etc.	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026